Cargando…
Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor: a meta-analyses
BACKGROUND: Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare pulmonary disease caused by functional deficiency of granulocyte-macrophage colony-stimulating factor (GM-CSF). GM-CSF therapy in aPAP has been reported effective in some studies. This meta-analyses aimed to evaluate whether GM-C...
Autores principales: | Sheng, Gaohong, Chen, Peng, Wei, Yanqiu, Chu, Jiaojiao, Cao, Xiaolei, Zhang, Hui-Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117963/ https://www.ncbi.nlm.nih.gov/pubmed/30165864 http://dx.doi.org/10.1186/s12931-018-0862-4 |
Ejemplares similares
-
Response to inhaled granulocyte‐macrophage colony‐stimulating factor in patient with mild‐to‐moderate autoimmune pulmonary alveolar proteinosis—24 months of follow‐up
por: Oterino‐Moreira, Iván, et al.
Publicado: (2023) -
Idiopathic Pulmonary Alveolar Proteinosis as an Autoimmune Disease with Neutralizing Antibody against Granulocyte/Macrophage Colony-Stimulating Factor
por: Kitamura, Takayuki, et al.
Publicado: (1999) -
Therapeutic effect of subcutaneous injection of low dose recombinant human granulocyte-macrophage colony-stimulating factor on pulmonary alveolar proteinosis
por: Zhang, Fen, et al.
Publicado: (2020) -
Proteogenomic analysis of granulocyte macrophage colony- stimulating factor autoantibodies in the blood of a patient with autoimmune pulmonary alveolar proteinosis
por: Hashimoto, Atsushi, et al.
Publicado: (2020) -
Whole lung lavage combined with Granulocyte-macrophage colony stimulating factor inhalation for an adult case of refractory pulmonary alveolar proteinosis
por: Yu, Hong yan, et al.
Publicado: (2014)